May 9 |
Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript
|
May 9 |
Anavex Life Sciences GAAP EPS of -$0.13 misses by $0.02
|
May 9 |
Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
|
May 8 |
Anavex Life Sciences Q2 2024 Earnings Preview
|
May 2 |
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
|
Apr 11 |
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
|
Mar 25 |
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 18 |
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
|
Feb 26 |
12 $10 Stocks That Will Triple
|
Feb 26 |
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
|